Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Tse

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|February 16, 2022
Targeted isolation of panels of diverse human protective broadly neutralizing antibodies against SARS-like virusesWan-Ting He, Rami Musharrafieh, Ge Song, et al.
Cell Reports|April 12, 2024
SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epitheliaRita M Meganck, Caitlin E Edwards, Michael L Mallory, et al.
Immunity|March 8, 2023
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly diseasePanpan Zhou, Ge Song, Hejun Liu, et al.
Science (New York, N.Y.)|January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Journal of Clinical Microbiology|July 21, 2021
Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization AssaysAnton M Sholukh, Andrew Fiore-Gartland, Emily S Ford, et al.
Science (New York, N.Y.)|June 17, 2020
Broad neutralization of SARS-related viruses by human monoclonal antibodiesAnna Z Wec, Daniel Wrapp, Andrew S Herbert, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike proteinAnna Z Wec, Daniel Wrapp, Andrew S Herbert, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeysKevin O Saunders, Esther Lee, Robert Parks, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Cell|June 12, 2020
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory TractYixuan J Hou, Kenichi Okuda, Caitlin E Edwards, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|February 16, 2022
Targeted isolation of panels of diverse human protective broadly neutralizing antibodies against SARS-like virusesWan-Ting He, Rami Musharrafieh, Ge Song, et al.
Cell Reports|April 12, 2024
SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epitheliaRita M Meganck, Caitlin E Edwards, Michael L Mallory, et al.
Immunity|March 8, 2023
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly diseasePanpan Zhou, Ge Song, Hejun Liu, et al.
Science (New York, N.Y.)|January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Journal of Clinical Microbiology|July 21, 2021
Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization AssaysAnton M Sholukh, Andrew Fiore-Gartland, Emily S Ford, et al.
Science (New York, N.Y.)|June 17, 2020
Broad neutralization of SARS-related viruses by human monoclonal antibodiesAnna Z Wec, Daniel Wrapp, Andrew S Herbert, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike proteinAnna Z Wec, Daniel Wrapp, Andrew S Herbert, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeysKevin O Saunders, Esther Lee, Robert Parks, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Cell|June 12, 2020
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory TractYixuan J Hou, Kenichi Okuda, Caitlin E Edwards, et al.
Pageof 9